Arcturus Therapeutics
ARCT
#9100
Rank
ยฃ0.12 B
Marketcap
ยฃ4.44
Share price
-1.00%
Change (1 day)
-58.73%
Change (1 year)

Revenue for Arcturus Therapeutics (ARCT)

Revenue in 2026 (TTM): ยฃ31.12 Million

According to Arcturus Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ31.67 Million. In 2025 the company made a revenue of ยฃ49.91 Million a decrease over the revenue in the year 2024 that were of ยฃ0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arcturus Therapeutics from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ31.12 M-37.64%
2025 ยฃ49.91 M-54.74%
2024 ยฃ0.11 B-10.94%
2023 ยฃ0.12 B-27.2%
2022 ยฃ0.17 B1757.53%
2021 ยฃ9.15 M30.83%
2020 ยฃ6.99 M-55.86%
2019 ยฃ15.85 M27.75%
2018 ยฃ12.41 M-16.37%
2017 ยฃ14.83 M
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas
NRC Health
NRC
ยฃ0.10 B 227.34%๐Ÿ‡บ๐Ÿ‡ธ USA